Seer Files Definitive Proxy for Contested Annual Meeting, Urges Vote Against Activist Nominees and For Poison Pill

summarizeSummary

Seer, Inc. has filed its definitive proxy statement for its upcoming Annual Meeting, formalizing its defense against an activist investor's proxy contest for board seats and seeking shareholder ratification of its Tax Benefit Preservation Plan (poison pill).

check_boxKey Events

• Proxy Contest for Board Control

  Seer, Inc. has filed its definitive proxy statement for its Annual Meeting on July 28, 2026, where shareholders will vote on the election of seven directors. This is a contested election, with the current board recommending its seven nominees and activist investor Radoff-JEC Group nominating three opposing candidates. The board urges shareholders to vote *only* for its nominees using the BLUE proxy card.

• Ratification of Tax Benefit Preservation Plan (Poison Pill)

  Shareholders are asked to ratify the Tax Benefit Preservation Plan, adopted in February 2026, which is designed to protect the company's approximately $282.5 million in federal net operating loss carryforwards (NOLs) by deterring any person or group from acquiring 4.9% or more of the common stock without board approval. The plan would expire on February 25, 2027, if not ratified.

• Board Rejects Activist Acquisition Offers

  The filing reiterates the board's unanimous rejection of multiple unsolicited, non-binding acquisition proposals from the Radoff-JEC Group, including the latest offer of $2.40 per share plus a contingent value right, stating these offers significantly undervalue the company.

• Executive Compensation Advisory Vote

  Shareholders will cast a non-binding advisory vote to approve named executive officer compensation for 2025. The board recommends a 'FOR' vote, noting that no new equity grants were made in 2025 due to a prior stock option repricing.

auto_awesomeAnalysis

This definitive proxy statement is a critical development in the ongoing battle for control of Seer, Inc. The company is actively defending against activist investor Radoff-JEC Group, who is seeking to elect three directors and has made multiple unsolicited acquisition proposals, all rejected by the board. The board's strong recommendation to vote *only* for its nominees and against the activist's slate underscores the high stakes of this proxy contest. Furthermore, the request for shareholder ratification of the Tax Benefit Preservation Plan (poison pill) is a direct defensive maneuver aimed at preventing the activist from increasing its stake and potentially forcing a sale or significant strategic shift. This plan is crucial for protecting the company's substantial net operating loss carryforwards, which could be impaired by an ownership change. The outcome of the July 28, 2026, Annual Meeting will determine the future composition of Seer's board and could significantly influence its strategic direction, including its stance on potential M&A and its ability to utilize its tax assets.